Abstract
Introduction
Reducing allogeneic blood transfusions remains a challenge in total knee arthroplasty. Patients with preoperative anemia have a particularly high risk for perioperative blood transfusions.
Materials and methods
176 anemic patients (Hb < 13.5 g/dl) undergoing total knee replacement were prospectively evaluated to compare the effect of a perioperative cell saver (26 patients), intraoperative fibrin sealants (5 ml Evicel®, Johnson & Johnson Wound Management, Ethicon, Somerville, NJ) (45 patients), preoperative autologous blood donation (PABD) (21 patients), the combination of fibrin sealants and preoperative autologous blood donation (44) and no intervention (40 patients) on perioperative blood loss and transfusion requirements.
Results
All protocols resulted in significant reduction of allogeneic blood transfusions. Transfusion rates were similar with the use of PABD (19 %), Evicel® (18 %), and cell saver (19 %), all significantly lower than the control group (38 %, p < 0.05). Combining Evicel® with PABD resulted in significantly higher wastage of autologous units (p < 0.05) with no significant reduction in allogeneic transfusion rate (14 %). The use of fibrin sealant resulted in a significant reduction of blood loss compared to the PABD group (603 vs. 810 ml, p < 0.005) as well as the control group (603 vs. 822 ml, p < 0.005).
Conclusions
While PABD proved to be the most cost-effective treatment option in anemic patients, fibrin sealants and cell saver show similar reduction in allogeneic transfusion rates compared to controls. The combination of fibrin sealants and PABD is not cost-effective and increases the number of wasted units.
Similar content being viewed by others
References
Spahn DR (2010) Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 113(2):482–495. doi:10.1097/ALN.0b013e3181e08e97
Noticewala MS, Nyce JD, Wang W, Geller JA, Macaulay W (2012) Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplast 27(6):961–967. doi:10.1016/j.arth.2011.10.008
Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P (2012) Estimating the transfusion risk following total knee arthroplasty. Orthopedics 35(10):e1465–e1471. doi:10.3928/01477447-20120919-13
Kim S, Altneu E, Monsef JB, King EA, Sculco TP, Boettner F (2011) Nonanemic patients do not benefit from autologous blood donation before total knee replacement. HSS J: Musculoskelet J Hosp Special Surg 7(2):141–144. doi:10.1007/s11420-011-9200-9
Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C (2002) Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 84-A(2):216–220
Husted H, Holm G, Jacobsen S (2008) Predictors of length of stay and patient satisfaction after hip and knee replacement surgery: fast-track experience in 712 patients. Acta Orthop 79(2):168–173. doi:10.1080/17453670710014941
Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR (2011) Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 378(9800):1396–1407. doi:10.1016/S0140-6736(11)61381-0
Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81(1):2–10
Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE (2004) Risks associated with blood transfusion after total knee arthroplasty. J Arthroplast 19(3):281–287
Sinclair KC, Clarke HD, Noble BN (2009) Blood management in total knee arthroplasty: a comparison of techniques. Orthopedics 32(1):19
Bern MM, Bierbaum BE, Katz JN, Losina E (2006) Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty. Transfus Med 16(5):313–319. doi:10.1111/j.1365-3148.2006.00701.x
Forgie MA, Wells PS, Laupacis A, Fergusson D (1998) Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International study of perioperative transfusion (ISPOT) Investigators. Arch Intern Med 158(6):610–616
Henry DA, Carless PA, Moxey AJ, O’Connell D, Forgie MA, Wells PS, Fergusson D (2002) Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2):CD003602. doi:10.1002/14651858.CD003602
Sculco TP, Gallina J (1999) Blood management experience: relationship between autologous blood donation and transfusion in orthopedic surgery. Orthopedics 22(1 Suppl):s129–s134
Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL (2000) Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am 82(1):89–100
Keating EM, Meding JB, Faris PM, Ritter MA (1998) Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 357:50–59
Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B (1993) The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 33(7):544–551
Thoms RJ, Marwin SE (2009) The role of fibrin sealants in orthopaedic surgery. J Am Acad Orthop Surg 17(12):727–736
Carless PA, Henry DA, Anthony DM (2003) Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev (2):CD004171. doi:10.1002/14651858.CD004171
Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H (1999) The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 81(11):1580–1588
Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD (2001) Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 83-A(10):1503–1505
Sculco TP (1998) Global blood management in orthopaedic surgery. Clin Orthop Relat Res 357:43–49
Wang GJ, Goldthwaite CA Jr, Burks S, Crawford R, Spotnitz WD (2003) Fibrin sealant reduces perioperative blood loss in total hip replacement. J Long Term Eff Med Implants 13(5):399–411
Everts PA, Devilee RJ, Oosterbos CJ, Mahoney CB, Schattenkerk ME, Knape JT, van Zundert A (2007) Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc: Off J ESSKA 15(7):888–894. doi:10.1007/s00167-007-0296-x
Mawatari M, Higo T, Tsutsumi Y, Shigematsu M, Hotokebuchi T (2006) Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases. J Orthop Surg (Hong Kong) 14(2):117–121
Flynn JC, Metzger CR, Csencsitz TA (1982) Intraoperative autotransfusion (IAT) in spinal surgery. Spine 7(5):432–435
Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA (2010) Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (4):CD001888. doi:10.1002/14651858.CD001888.pub4
Billote DB, Glisson SN, Green D, Wixson RL (2002) A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 84-A(8):1299–1304
Heyse TJ, Haas SB, Drinkwater D, Lyman S, Kim HJ, Kahn BA, Figgie MP (2013) Intraarticular fibrinogen does not reduce blood loss in TKA: a randomized clinical trial. Clin Orthop Relat Res. doi:10.1007/s11999-013-3036-1
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bou Monsef, J., Buckup, J., Waldstein, W. et al. Fibrin sealants or cell saver eliminate the need for autologous blood donation in anemic patients undergoing primary total knee arthroplasty. Arch Orthop Trauma Surg 134, 53–58 (2014). https://doi.org/10.1007/s00402-013-1876-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-013-1876-5